ロード中...
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
BACKGROUND: Oral disease-modifying therapies offer equivalent or superior efficacy and greater convenience versus injectable options. OBJECTIVES: To compare patient-reported experiences of fingolimod and dimethyl fumarate. METHODS: Adult relapsing-remitting multiple sclerosis patients treated with f...
保存先:
| 出版年: | BMC Res Notes |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5015319/ https://ncbi.nlm.nih.gov/pubmed/27604188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13104-016-2243-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|